Literature DB >> 30622168

Temperoammonic Stimulation Depotentiates Schaffer Collateral LTP via p38 MAPK Downstream of Adenosine A1 Receptors.

Yukitoshi Izumi1,2,3, Charles F Zorumski4,5,2,3.   

Abstract

We previously found that low-frequency stimulation of direct temperoammonic (TA) inputs to hippocampal area CA1 depotentiates previously established long-term potentiation in the Schaffer collateral (SC) pathway through complex signaling involving dopamine, endocannabinoids, neuregulin-1, GABA, and adenosine, with adenosine being the most distal modulator identified to date. In the present studies, we examined mechanisms contributing to the effects of adenosine in hippocampal slices from male albino rats. We found that extracellular conversion of ATP to adenosine via an ectonucleotidase contributes significantly to TA-mediated SC depotentiation and the depotentiation resulting from block of adenosine transport. Adenosine-mediated SC depotentiation does not involve activation of c-Jun N-terminal protein kinase, serine phosphatases, or nitric oxide synthase, unlike homosynaptic SC depotentiation. Rather, adenosine-induced depotentiation is inhibited by specific antagonists of p38 MAPK, but not by a structural analog that does not inhibit p38. Additionally, using antagonists with relative selectivity for p38 subtypes, it appears that TA-induced SC depotentiation most likely involves p38 MAPK β. These findings have implications for understanding the role of adenosine and other extrahippocampal and intrahippocampal modulators in regulating SC synaptic function and the contributions of these modulators to the cognitive dysfunction associated with neuropsychiatric illnesses.SIGNIFICANCE STATEMENT Low-frequency stimulation of temperoammonic (TA) inputs to stratum lacunosum moleculare of hippocampal area CA1 heterosynaptically depotentiates long-term potentiation of Schaffer collateral (SC) synapses. TA-induced SC depotentiation involves complex signaling including dopamine, endocannabinoids, GABA, and adenosine, with adenosine serving as the most downstream messenger in the cascade identified to date. The present results indicate that TA-induced depotentiation requires intact inputs from entorhinal cortex and that adenosine ultimately drives depotentiation via activation of p38 MAPK. These studies have implications for understanding the cognitive dysfunction of psychiatric illnesses and certain abused drugs.
Copyright © 2019 the authors 0270-6474/19/391783-10$15.00/0.

Entities:  

Keywords:  GABA; dopamine; endocannabinoids; hippocampus; neuregulin; perforant path

Mesh:

Substances:

Year:  2019        PMID: 30622168      PMCID: PMC6407293          DOI: 10.1523/JNEUROSCI.1362-18.2018

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  Proactive and retrograde effects on LTP produced by theta pulse stimulation: mechanisms and characteristics of LTP reversal in vitro.

Authors:  U Staubli; D Chun
Journal:  Learn Mem       Date:  1996 Sep-Oct       Impact factor: 2.460

2.  Topographically based search for an "Ethogram" among a series of novel D(4) dopamine receptor agonists and antagonists.

Authors:  J J Clifford; J L Waddington
Journal:  Neuropsychopharmacology       Date:  2000-05       Impact factor: 7.853

3.  Effects of A1 and A2 adenosine receptor antagonists on the induction and reversal of long-term potentiation in guinea pig hippocampal slices of CA1 neurons.

Authors:  S Fujii; H Kato; K Ito; S Itoh; Y Yamazaki; H Sasaki; Y Kuroda
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

4.  Modulation of long-term potentiation induction in the hippocampus by N-methyl-D-aspartate-mediated presynaptic inhibition.

Authors:  K Kato; S T Li; C F Zorumski
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Characterization of the mechanism underlying the reversal of long term potentiation by low frequency stimulation at hippocampal CA1 synapses.

Authors:  C C Huang; Y C Liang; K S Hsu
Journal:  J Biol Chem       Date:  2001-10-25       Impact factor: 5.157

6.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

7.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.

Authors:  B L Bennett; D T Sasaki; B W Murray; E C O'Leary; S T Sakata; W Xu; J C Leisten; A Motiwala; S Pierce; Y Satoh; S S Bhagwat; A M Manning; D W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

8.  The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker.

Authors:  L W Swanson; B K Hartman
Journal:  J Comp Neurol       Date:  1975-10-15       Impact factor: 3.215

9.  Effects of adenosine receptors on the synaptic and EPSP-spike components of long-term potentiation and depotentiation in the guinea-pig hippocampus.

Authors:  S Fujii; Y Kuroda; K i Ito; K Kaneko; H Kato
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

10.  A role for extracellular adenosine in time-dependent reversal of long-term potentiation by low-frequency stimulation at hippocampal CA1 synapses.

Authors:  C C Huang; Y C Liang; K S Hsu
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

View more
  3 in total

1.  Sex Differences in the Role of CNIH3 on Spatial Memory and Synaptic Plasticity.

Authors:  Hannah E Frye; Yukitoshi Izumi; Alexis N Harris; Sidney B Williams; Christopher R Trousdale; Min-Yu Sun; Andrew D Sauerbeck; Terrance T Kummer; Steven Mennerick; Charles F Zorumski; Elliot C Nelson; Joseph D Dougherty; Jose A Morón
Journal:  Biol Psychiatry       Date:  2021-07-23       Impact factor: 13.382

2.  G-Protein-Gated Inwardly Rectifying Potassium (Kir3/GIRK) Channels Govern Synaptic Plasticity That Supports Hippocampal-Dependent Cognitive Functions in Male Mice.

Authors:  Souhail Djebari; Guillermo Iborra-Lázaro; Sara Temprano-Carazo; Irene Sánchez-Rodríguez; Mauricio O Nava-Mesa; Alejandro Múnera; Agnès Gruart; José M Delgado-García; Lydia Jiménez-Díaz; Juan D Navarro-López
Journal:  J Neurosci       Date:  2021-07-14       Impact factor: 6.167

Review 3.  When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.

Authors:  Santosh R D'Mello
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.